Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 125 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Tsolaki, Magda  [Clear All Filters]
2012
Proitsi, P., Lupton M. K., Dudbridge F., Tsolaki M., Hamilton G., Daniilidou M., et al. (2012).  Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation.. Neurobiol Aging. 33(8), 1843.e9-17.
Jacobs, H. I. L., Visser P. Jelle, Van Boxtel M. P. J., Frisoni G. B., Tsolaki M., Papapostolou P., et al. (2012).  Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent.. Neurobiol Aging. 33(1), 201.e1-8.
Koliaki, C. C., Messini C., & Tsolaki M. (2012).  Clinical efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors, in patients with cognitive impairment: a comparative open study.. CNS Neurosci Ther. 18(4), 302-12.
Tarnanas, I., Laskaris N., & Tsolaki M. (2012).  On the comparison of VR-responses, as performance measures in prospective memory, with auditory P300 responses in MCI detection.. Stud Health Technol Inform. 181, 156-61.
Liu, Y., Julkunen V., Paajanen T., Westman E., Wahlund L-O., Aitken A., et al. (2012).  Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis.. Neuroradiology. 54(9), 929-38.
Lunnon, K., Ibrahim Z., Proitsi P., Lourdusamy A., Newhouse S., Sattlecker M., et al. (2012).  Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.. J Alzheimers Dis. 30(3), 685-710.
Tagarakis, G. I., Voucharas C., Tsolaki F., Daskalopoulos M. E., Papaliagkas V., Parisis C., et al. (2012).  Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study.. J Cardiothorac Surg. 7, 25.
Gerrish, A., Russo G., Richards A., Moskvina V., Ivanov D., Harold D., et al. (2012).  The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.. J Alzheimers Dis. 28(2), 377-87.
Vos, S., van Rossum I., Burns L., Knol D., Scheltens P., Soininen H., et al. (2012).  Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.. Neurobiol Aging. 33(10), 2272-81.
Mangialasche, F., Xu W., Kivipelto M., Costanzi E., Ercolani S., Pigliautile M., et al. (2012).  Tocopherols and tocotrienols plasma levels are associated with cognitive impairment.. Neurobiol Aging. 33(10), 2282-90.
2011
Westman, E., Simmons A., Muehlboeck J-S., Mecocci P., Vellas B., Tsolaki M., et al. (2011).  AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.. Neuroimage. 58(3), 818-28.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2011).  The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.. Int J Geriatr Psychiatry. 26(1), 75-82.
Costafreda, S. G., Dinov I. D., Tu Z., Shi Y., Liu C-Y., Kloszewska I., et al. (2011).  Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment.. Neuroimage. 56(1), 212-9.
Liu, Y., Paajanen T., Zhang Y., Westman E., Wahlund L-O., Simmons A., et al. (2011).  Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study.. Neurobiol Aging. 32(7), 1198-206.
Furney, S. J., Kronenberg D., Simmons A., Güntert A., Dobson R. J., Proitsi P., et al. (2011).  Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.. J Alzheimers Dis. 26 Suppl 3, 395-405.
Lupton, M. K., Proitsi P., Danillidou M., Tsolaki M., Hamilton G., Wroe R., et al. (2011).  Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.. PLoS One. 6(2), e17298.
Daniilidou, M., Tsolaki M., Giannakouros T., & Nikolakaki E. (2011).  Detection of elevated antibodies against SR protein kinase 1 in the serum of Alzheimer's disease patients.. J Neuroimmunol. 238(1-2), 67-72.
Sikkes, S. A. M., Visser P. Jelle, Knol D. L., de Klerk E. S. M. de Lan, Tsolaki M., Frisoni G. B., et al. (2011).  Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study.. J Am Geriatr Soc. 59(12), 2273-81.
Tsolaki, M., Kounti F., Agogiatou C., Poptsi E., Bakoglidou E., Zafeiropoulou M., et al. (2011).  Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment.. Neurodegener Dis. 8(3), 138-45.
Fountoulakis, K. N., Pavlidis I., & Tsolaki M. (2011).  Life events and dementia: what is the nature of their relationship?. Psychiatry Res. 190(1), 156-8.
Westman, E., Simmons A., Zhang Y., Muehlboeck J-S., Tunnard C., Liu Y., et al. (2011).  Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.. Neuroimage. 54(2), 1178-87.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.